Effective Management of Pre-Extensively Drug-Resistant Tuberculous Meningoencephalomyelitis in Pregnant Patients Using a Bedaquiline and Delamanid Treatment Approach: A Case Study - Scorecard - MDSpire
Advertisement
Effective Management of Pre-Extensively Drug-Resistant Tuberculous Meningoencephalomyelitis in Pregnant Patients Using a Bedaquiline and Delamanid Treatment Approach: A Case Study
Clinical Scorecard: Effective Management of Pre-Extensively Drug-Resistant Tuberculous Meningoencephalomyelitis in Pregnant Patients Using a Bedaquiline and Delamanid Treatment Approach: A Case Study
At a Glance
Category
Detail
Condition
Pre-Extensively Drug-Resistant Tuberculous Meningoencephalomyelitis (pre-XDR-TBMEM) - a severe form of TB affecting the central nervous system.
Key Mechanisms
Use of Bedaquiline and Delamanid for treating drug-resistant tuberculosis, particularly in complex cases.
Target Population
Pregnant patients diagnosed with pre-XDR-TBMEM, requiring specialized care.
Care Setting
Multidisciplinary hospital care involving infectious disease specialists, obstetricians, and pharmacists.
Key Highlights
Successful use of Bdq/Dlm-based regimen in a critically ill pregnant patient with severe complications.
Management of TB-Sepsis and Neuro-IRIS during treatment, highlighting the challenges faced.
Favorable maternal and infant outcomes despite severe complications, with specific outcomes detailed.
Guideline-Based Recommendations
Diagnosis
Utilize targeted next-generation sequencing for confirming drug resistance, as per WHO guidelines.
Monitor CSF analysis for elevated pressure and cell counts, referencing relevant studies.
Management
Initiate empirical therapy with effective agents based on local resistance patterns, supported by local epidemiological data.
Optimize regimen based on resistance profile and clinical condition, with references to clinical guidelines.
Monitoring & Follow-up
Regular assessment of liver and renal function, with specific monitoring intervals.
Monitor inflammatory markers and SOFA score for sepsis, detailing the importance of each marker.
Risks
Potential teratogenic effects of anti-TB drugs, referencing studies on drug safety in pregnancy.
Risk of Neuro-IRIS and multi-organ dysfunction, with examples of management strategies.
Patient & Prescribing Data
Pregnant women with pre-XDR-TBMEM, emphasizing the need for tailored treatment plans.
Bedaquiline and Delamanid can be safely used with careful monitoring, detailing specific monitoring protocols.
Clinical Best Practices
Employ a multidisciplinary approach for complex cases, specifying roles of each team member.
Prioritize rapid bactericidal activity in critically ill patients, with examples of effective agents.
Ensure thorough follow-up imaging and assessments post-treatment, detailing the types of assessments needed.
